EVEREST ORGANICS
Back to Income Statement
|
EVEREST ORGANICS Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹159 Cr | ₹197 Cr | ₹183 Cr | ₹200 Cr | ₹182 Cr |
What is the latest Revenue of EVEREST ORGANICS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹159 Cr |
| Mar2024 | ₹197 Cr |
| Mar2023 | ₹183 Cr |
| Mar2022 | ₹200 Cr |
| Mar2021 | ₹182 Cr |
How is Revenue of EVEREST ORGANICS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹159 Cr | -19.15 | |
| Mar2024 | ₹197 Cr | 7.75 | |
| Mar2023 | ₹183 Cr | -8.50 | |
| Mar2022 | ₹200 Cr | 10.18 | |
| Mar2021 | ₹182 Cr | - | |
Compare Revenue of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹280.6 Cr | -5.8% | -6.5% | -28.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | -5.8% |
-6.5% |
-28.9% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses